Cordoba, Argentina

Gloria L Silva

This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 2006.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gloria L. Silva: Innovator in Modulating P-glycoproteins

Introduction

Gloria L. Silva is a prominent inventor based in Cordoba, Argentina. She has made significant contributions to the field of pharmacology through her innovative research and development of compounds that modulate the activity of P-glycoproteins. Her work addresses critical challenges in overcoming multidrug resistance in therapeutic applications.

Latest Patents

Gloria holds 1 patent that focuses on compounds and methods for modulating P-glycoprotein activity. This patent discloses methods utilizing compounds derived from her research, which can enhance the performance of therapeutic drugs, including chemotherapeutic agents and antibiotics. Her innovative approach aims to improve treatment outcomes for patients facing drug resistance.

Career Highlights

Gloria is affiliated with the University of Illinois, where she conducts her research and collaborates with fellow scientists. Her work has garnered attention for its potential to revolutionize therapeutic strategies in medicine. She is recognized for her dedication to advancing the understanding of drug interactions and resistance mechanisms.

Collaborations

Throughout her career, Gloria has collaborated with esteemed colleagues, including Baoliang Cui and Min You. These partnerships have enriched her research and contributed to the development of groundbreaking solutions in the field of pharmacology.

Conclusion

Gloria L. Silva is a trailblazer in the realm of drug modulation, with her innovative patent addressing significant medical challenges. Her contributions continue to pave the way for advancements in therapeutic drug efficacy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…